News

The AHA voiced support for the Telehealth Modernization Act (S.368), legislation that would remove geographic and originating site restrictions to allow patients to receive telehealth in their homes and other locations.

The federal government has agreed to purchase at least 100,000 doses of the combination monoclonal antibody therapy bamlanivimab and etesevimab, Eli Lilly and Company announced.

The Food and Drug Administration granted an emergency use authorization for Johnson & Johnson’s single-dose COVID-19 vaccine.

The House of Representatives voted 219-212 to approve a modified version of the American Rescue Plan Act of 2021, legislation to provide reconciliation protection for a roughly $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and health systems.

The Centers for Medicare & Medicaid Services released guidance clarifying federal requirements for health plans to cover certain items and services related to diagnostic testing for COVID-19 without cost-sharing, prior authorization or other medical management requirements.

During our rapid response to the COVID-19 pandemic, hospitals and health systems have developed new ways of collecting, evaluating and sharing data to improve patient care. It’s one way the pandemic is reshaping health care now and into the future.

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee recommended the approval of Johnson & Johnson’s COVID-19 vaccine candidate.

Sens. Dan Sullivan, R-Alaska, and Chris Murphy, D-Conn., announced they will introduce the Leveraging Integrated Networks in Communities to Address Social Needs Act, AHA-supported legislation that would provide funding for states to create or enhance public-private partnerships to coordinate health and social services.

The Substance Abuse and Mental Health Services Administration will host a March 3 roundtable discussion on the academic, social and emotional impacts of distance learning on children during the COVID-19 pandemic.

Due to the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will apply an automatic extreme and uncontrollable circumstances policy to all clinicians participating as individuals in the Quality Payment Program’s Merit-based Incentive Payment System for the 2020 performance period, the agency announced.